You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 2, January 14, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Bioterrorism
 •Alert me on articles by topic

Treatment of Sarin Exposure—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: I agree with Dr Krivoy and colleagues that a search is underway for an alternative or adjunct to diazepam as an antiseizure treatment. Shih and McDonough1 have shown that its effectiveness is decreased when administered 40 minutes after seizure onset. However, in another study McDonough et al2 also found that diazepam was the most potent compound when administered 40 minutes after seizure onset compared with 8 anticholinergic drugs, including benactyzine.

Wood and Tattersall3 found that NMDA antagonists AP5 and MK-801 failed to block second population of spikes and spontaneous discharges induced by the nerve agent soman. Their results are consistent with the reported lack of effectiveness of NMDA antagonists in other seizure models. In some cases, the NMDA antagonists had a proconvulsant effect.

Koplovitz et al4 found that a combination of diazepam and an anticholinergic drug was very effective in terminating soman-induced seizures, regardless of whether treatment is . . . [Full Text of this Article]

Maj Ernest C. Lee, MD, MPH, USAF, MC
Occupational and Environmental Medicine
Harvard School of Public Health
Boston, Mass


RELATED ARTICLES

Treatment of Sarin Exposure
Amir Krivoy, Ido Layish, Eran Rotman, and Yoav Yehezkelli
JAMA. 2004;291(2):181.
EXTRACT | FULL TEXT  

Treatment of Sarin Exposure
Peter DeBalli and D. Ryan Cook
JAMA. 2004;291(2):181-182.
EXTRACT | FULL TEXT  

Treatment of Sarin Exposure
Joshua G. Schier and Robert S. Hoffman
JAMA. 2004;291(2):182.
EXTRACT | FULL TEXT  

Clinical Manifestations of Sarin Nerve Gas Exposure
Ernest C. Lee
JAMA. 2003;290(5):659-662.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.